Sorafenib as first line treatment for advanced liver cancer-are expiries
Наслов
Sorafenib as first line treatment for advanced liver cancer-are expiries
Идентификатор
/unibl/sci/idNaucniRad:25642
Тип
Пронађите сличне уносеConference Paper
Датум
Библиографски цитат
Z. Gojković, S. Jungić, I. Rakita, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, S. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer-are expiries, This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista), 2012
Презентовано
14th World Congres of Gastrointestinal Cancer
Је дио
Пронађите сличне уносеThis article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista)
Листа аутора
Position: 9054 (35 views)